Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
BMC Biochemistry|January 8, 2013
The COP1 E3-ligase interacts with FIP200, a key regulator of mammalian autophagySaori Kobayashi, Noriko Yoneda-Kato, Nagisa Itahara, et al.
Blood Advances|January 4, 2018
Myeloid leukemia factor 1 stabilizes tumor suppressor C/EBPα to prevent Trib1-driven acute myeloid leukemiaIkuko Nakamae, Jun-Ya Kato, Takashi Yokoyama, et al.
Scientific Reports|December 27, 2022
Preclinical evaluation of pentagamavunone-1 as monotherapy and combination therapy for pancreatic cancer in multiple xenograft modelsNaoki Kamitani, Ikuko Nakamae, Noriko Yoneda-Kato, et al.
The FEBS Journal|January 18, 2008
The myeloid leukemia factor interacts with COP9 signalosome subunit 3 in Drosophila melanogasterWakana Sugano, Katsuhito Ohno, Noriko Yoneda-Kato, et al.
Cancer Gene Therapy|September 1, 2025
Pentagamavunone-1 targets excessive MYCN/NCYM expression mediated by mitotic arrest to suppress hepatocellular carcinoma proliferationDhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato, et al.
Journal of Bacteriology|December 17, 2004
Transcriptional control by A-factor of two trypsin genes in Streptomyces griseusJun-Ya Kato, Won-Jae Chi, Yasuo Ohnishi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 28, 2021
CCA-1.1, a Novel Curcumin Analog, Exerts Cytotoxic anti- Migratory Activity toward TNBC and HER2-Enriched Breast Cancer CellsDhania Novitasari, Riris Istighfari Jenie, Rohmad Yudi Utomo, et al.
Scientific Reports|February 3, 2018
Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growthYonika Arum Larasati, Noriko Yoneda-Kato, Ikuko Nakamae, et al.
Journal of Advanced Pharmaceutical Technology & Research|December 18, 2023
Tumour-suppressive effects of curcumin analogs CCA-1.1 and Pentagamavunone-1 in colon cancer: In vivo and in vitro studiesFebri Wulandari, Muthi Ikawati, Sitarina Widyarini, et al.
Pageof 6